Investments in Innovative Technologies Enable Growth Opportunities
This report covers the heart valves industry, including aortic, mitral, tricuspid, and pulmonary valves. The report addresses critical questions such as market sizes, growth rates, opportunities, strategic imperatives, technology impact, and untapped potential in the industry.
The analysis shows that the industry is gaining traction due to the increasing adoption of transcatheter technologies. Transcatheter aortic valve replacement (TAVR) procedures recorded lucrative growth in the past few years and will continue to grow in the forecast period.
Industry participants are developing transcatheter mitral and tricuspid valve technologies to capture the next growth phase. The report finds that the heart valves industry has reached an inflection point due to the development of many new technologies as well as the rise in clinical evidence and regulatory approval for these technologies.
Regional coverage includes North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa. North America is the largest market due to the presence of many large companies and emerging companies. The industry is growing rapidly in Asia-Pacific because of the high number of people suffering from heart valve diseases and growing awareness and accessibility to heart valve technologies.
The study period is 2021-2028, with 2023 as the base year and 2024-2028 as the forecast period.
